Product Cancellation Order for Certain Pesticide Registrations and Amendments To Terminate Uses; Amendment, 2415 [2021-00322]
Download as PDF
Federal Register / Vol. 86, No. 7 / Tuesday, January 12, 2021 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
businesses that EPA, via DOJ, will
provide certain information to the
parties and the Court in the matter of
Natural Resources Defense Council v.
U.S. Environmental Protection Agency
et al., Case No. 20–72794 (9th Cir.)
(‘‘TCVP litigation’’). The information is
contained in documents that have been
submitted to EPA pursuant to FIFRA
and FFDCA by pesticide registrants or
other data-submitters, including
information that has been claimed to be,
or determined to potentially contain,
CBI. In the TCVP Litigation, the
Petitioner seeks judicial review of EPA’s
July 21, 2020 denial of the Natural
Resources Defense Council’s 2009
petition requesting that EPA cancel all
pet uses of the pesticide
tetrachlorvinphos (TCVP) registered
under FIFRA.
The documents are being produced as
part of the Administrative Record of the
decision at issue and include
documents that registrants or other datasubmitters may have submitted to EPA
regarding the pesticide TCVP, and that
may be subject to various release
restrictions under federal law. The
information includes documents
submitted with pesticide registration
applications and may include CBI as
well as scientific studies subject to the
disclosure restrictions of FIFRA section
10(g), 7 U.S.C. 136h(g).
All documents that may be subject to
release restrictions under federal law
will be designated as ‘‘Confidential or
Restricted Information’’ in the certified
list of record materials that EPA will file
in this case. Further, EPA intends to
seek a Protective Order that would
preclude public disclosure of any such
documents by the parties in this action
who have received the information from
EPA, and that would limit the use of
such documents to litigation purposes
only. EPA would only produce such
documents in accordance with the
Protective Order. The anticipated
Protective Order would require that
such documents would be filed under
seal and would not be available for
public review, unless the information
contained in the document has been
determined to not be subject to FIFRA
section 10(g) and all CBI has been
redacted.
Authority: 7 U.S.C. 136 et seq.; 21 U.S.C.
301 et seq.
Dated: December 1, 2020.
Mary Reaves,
Acting Director, Pesticide Re-Evaluation
Division, Office of Pesticide Programs.
[FR Doc. 2021–00324 Filed 1–11–21; 8:45 am]
BILLING CODE 6560–50–P
VerDate Sep<11>2014
17:09 Jan 11, 2021
Jkt 253001
ENVIRONMENTAL PROTECTION
AGENCY
[EPA–HQ–OPP–2018–0014; FRL–10017–33]
Product Cancellation Order for Certain
Pesticide Registrations and
Amendments To Terminate Uses;
Amendment
Environmental Protection
Agency (EPA).
ACTION: Notice.
AGENCY:
EPA issued a notice in the
Federal Register of March 19, 2019,
concerning the cancellations voluntarily
requested by the registrants and
accepted by the Agency but have not yet
become effective. This notice is being
issued to amend the cancellation order,
as requested by the registrant, by
amending the effective date of the
cancellation and the existing stocks
provision for the two triadimefon
registrations (264–736 and 264–740).
DATES: The Federal Register of March
19, 2019, announced the voluntarily
cancellation of two triadimefon
registrations (264–736 and 264–740)
that the registrant requested.
FOR FURTHER INFORMATION CONTACT:
Matthew B. Khan, Pesticide
Reevaluation Division (7502P), Office of
Pesticide Programs, Environmental
Protection Agency, 1200 Pennsylvania
Ave. NW, Washington, DC 20460–0001;
telephone number: (703) 347–8613
email address: khan.matthew@epa.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. General Information
A. Does this action apply to me?
This action is directed to the public
in general, and may be of interest to a
wide range of stakeholders including
environmental, human health, and
agricultural advocates; the chemical
industry; pesticide users; and members
of the public interested in the sale,
distribution, or use of pesticides. Since
others also may be interested, the
Agency has not attempted to describe all
the specific entities that may be affected
by this action.
B. How can I get copies of this document
and other related information?
The docket for this action, identified
by docket identification (ID) number
EPA–HQ–OPP–2018–0014, is available
at https://www.regulations.gov or at the
Office of Pesticide Programs Regulatory
Public Docket (OPP Docket) in the
Environmental Protection Agency
Docket Center (EPA/DC), West William
Jefferson Clinton Bldg., Rm. 3334, 1301
Constitution Ave. NW, Washington, DC
20460–0001.
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
2415
Due to the public health concerns
related to COVID–19, the EPA Docket
Center (EPA/DC) and Reading Room is
closed to visitors with limited
exceptions. The staff continues to
provide remote customer service via
email, phone, and webform. For the
latest status information on EPA/DC
services and docket access, visit https://
www.epa.gov/dockets.
II. What does this amendment do?
This notice is being issued to amend
the voluntary cancellation effective date
for the two triadimefon registrations
listed in Table 1 of the cancellation
notice that published in the Federal
Register on March 19, 2019 (84 FR
10068) (FRL–9989–85), which was
corrected in the Federal Register on
May 29, 2019 (84 FR 24778) (FRL–9992–
29). The agency was made aware by
Bayer that the final shipments of their
triadimefon technical registrations were
delayed due to quarantine measures.
Since the risk assessments for
triadimefon have not yet been
conducted and no risks of concern have
been identified at this time, the agency
has determined that this extension will
not pose a significant risk. This
amendment grants the two-month
extension for the two triadimefon
registrations (264–736 and 264–740).
The effective cancellation date for these
registrations is now February 28, 2020,
with a one-year existing stocks
provision.
Authority: 7 U.S.C. 136 et seq.
Dated: November 25, 2020.
Mary Reaves,
Acting Director, Pesticide Re-Evaluation
Division, Office of Pesticide Programs.
[FR Doc. 2021–00322 Filed 1–11–21; 8:45 am]
BILLING CODE 6560–50–P
EQUAL EMPLOYMENT OPPORTUNITY
COMMISSION
Sunshine Act Meeting
Friday, January 15, 2021,
1:00 p.m. Eastern Time.
PLACE: Because of the COVID–19
pandemic, the meeting will be held as
an audio-only conference. The public
may listen to the audio-only conference
by following the instructions that will
be posted on www.eeoc.gov 24 hours
before the meeting. Closed captioning
services will be available.
STATUS: The meeting will be open to the
public.
MATTER TO BE CONSIDERED: The
following item will be considered:
TIME AND DATE:
E:\FR\FM\12JAN1.SGM
12JAN1
Agencies
[Federal Register Volume 86, Number 7 (Tuesday, January 12, 2021)]
[Notices]
[Page 2415]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-00322]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-OPP-2018-0014; FRL-10017-33]
Product Cancellation Order for Certain Pesticide Registrations
and Amendments To Terminate Uses; Amendment
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: EPA issued a notice in the Federal Register of March 19, 2019,
concerning the cancellations voluntarily requested by the registrants
and accepted by the Agency but have not yet become effective. This
notice is being issued to amend the cancellation order, as requested by
the registrant, by amending the effective date of the cancellation and
the existing stocks provision for the two triadimefon registrations
(264-736 and 264-740).
DATES: The Federal Register of March 19, 2019, announced the
voluntarily cancellation of two triadimefon registrations (264-736 and
264-740) that the registrant requested.
FOR FURTHER INFORMATION CONTACT: Matthew B. Khan, Pesticide
Reevaluation Division (7502P), Office of Pesticide Programs,
Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington,
DC 20460-0001; telephone number: (703) 347-8613 email address:
[email protected].
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
This action is directed to the public in general, and may be of
interest to a wide range of stakeholders including environmental, human
health, and agricultural advocates; the chemical industry; pesticide
users; and members of the public interested in the sale, distribution,
or use of pesticides. Since others also may be interested, the Agency
has not attempted to describe all the specific entities that may be
affected by this action.
B. How can I get copies of this document and other related information?
The docket for this action, identified by docket identification
(ID) number EPA-HQ-OPP-2018-0014, is available at https://www.regulations.gov or at the Office of Pesticide Programs Regulatory
Public Docket (OPP Docket) in the Environmental Protection Agency
Docket Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334,
1301 Constitution Ave. NW, Washington, DC 20460-0001.
Due to the public health concerns related to COVID-19, the EPA
Docket Center (EPA/DC) and Reading Room is closed to visitors with
limited exceptions. The staff continues to provide remote customer
service via email, phone, and webform. For the latest status
information on EPA/DC services and docket access, visit https://www.epa.gov/dockets.
II. What does this amendment do?
This notice is being issued to amend the voluntary cancellation
effective date for the two triadimefon registrations listed in Table 1
of the cancellation notice that published in the Federal Register on
March 19, 2019 (84 FR 10068) (FRL-9989-85), which was corrected in the
Federal Register on May 29, 2019 (84 FR 24778) (FRL-9992-29). The
agency was made aware by Bayer that the final shipments of their
triadimefon technical registrations were delayed due to quarantine
measures. Since the risk assessments for triadimefon have not yet been
conducted and no risks of concern have been identified at this time,
the agency has determined that this extension will not pose a
significant risk. This amendment grants the two-month extension for the
two triadimefon registrations (264-736 and 264-740). The effective
cancellation date for these registrations is now February 28, 2020,
with a one-year existing stocks provision.
Authority: 7 U.S.C. 136 et seq.
Dated: November 25, 2020.
Mary Reaves,
Acting Director, Pesticide Re-Evaluation Division, Office of Pesticide
Programs.
[FR Doc. 2021-00322 Filed 1-11-21; 8:45 am]
BILLING CODE 6560-50-P